DataArt was recognized in the Hype Cycle™ for Life Science Clinical Development, 2022 by Gartner®, a company that delivers actionable, objective insight to executives and their teams. Its expert guidance and tools enable faster, smarter decisions and stronger performance on an organization’s mission-critical priorities.
"This Hype Cycle explores innovative technologies that are specifically relevant to life science clinical development programs in the pharmaceutical, biotechnology, diagnostics, medical device, research institution and contract research sectors."
"For two years in a row DataArt has been mentioned as a Sample Vendor in AI/ML for Clinical Development in the Gartner Hype Cycle report,” says SVP, Head of Healthcare & Life Sciences at DataArt, Daniel Piekarz. “We think, this is an amazing achievement that shows the expertise we possess across Healthcare, Life Sciences, and our AI/ML Centers of Excellence. We look forward to continuing to help our clients uncover the massive potential that exists within AI/ML innovation for developing new clinical therapies. From Drug Discovery, to Clinical Trial Matching, to Clinical Decision Support, & more AI/ML technologies are going to play a big part in advancing medicine."
For more information please visit gartner.com.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
